DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
SoftBank - 1 “ - 1 ” JP Morgan - 1 ” - 1 Charu Chanana - 1 Andrew Kelly - 1 Jason Weidman - 1 Sriparna Roy - 1
Top related locs:
Tokyo White Oak , Maryland U.S Japan Europe Bengaluru
Top related orgs:
Otsuka Holdings - 2 Tokyo Reuters - 1 Japan’s Nikkei - 1 Nikkei - 1 Tokyo - 1 SoftBank - 1 ARM Holding - 1 Tokio Marine Holdings Inc - 1

Search resuls for: "Otsuka Holdings"


2 mentions found


☆ Japan’s Nikkei hits 34-year high
  + stars: | 2024-02-13 | by ( ) edition.cnn.com   time to read: +2 min
Tokyo Reuters —Japan’s Nikkei share average closed at a fresh 34-year high on Tuesday as trading resumed after a long holiday weekend, with tech-related shares and strong corporate earnings supporting the benchmark stock index. The Nikkei climbed 2.89% to 37,963.97 to its highest since January 1990, after briefly breaching 38,000 points. The broader Topix rose 2.12%. Among other top gainers, Tokio Marine Holdings Inc and MS&AD Insurance Group Holdings Inc gained 11% and 10.82%, respectively. As the Nikkei climbs toward its all-time high, the US consumer price index (CPI) report out later on Tuesday will be in focus.
Persons: SoftBank, “, ” JP Morgan, ”, Charu Chanana Organizations: Tokyo Reuters, Japan’s Nikkei, Nikkei, Tokyo, SoftBank, ARM Holding, Tokio Marine Holdings Inc, Insurance, Holdings, CPI, Saxo Markets, Otsuka Holdings Locations: Tokyo
☆ US FDA panel votes against use of Medtronic's blood pressure treatment device
  + stars: | 2023-08-23 | by ( ) www.reuters.com   time to read: +2 min
The same panel on Tuesday voted in favor of rival ReCor's device for use in a surgery called renal denervation in patients whose high blood pressure cannot be controlled by drugs. Separately, while all panel members voted the device was safe to use, 6 of 13 voted against its effectiveness. Japan-based Otsuka Holdings' (4578.T) unit ReCor's device was shown to provide a benefit in lowering blood pressure in clinical trials. Medtronic's device helped to lower blood pressure at the doctor's clinic but not at home, which is considered a more accurate measure of blood pressure monitoring. The company was seeking the health regulator's nod for the device indicated for patients whose hypertension, or high blood pressure, cannot be controlled with drugs.
Persons: Andrew Kelly, Jason Weidman, Sriparna Roy, Krishna Chandra Eluri Organizations: Food and Drug Administration, FDA, REUTERS, U.S . Food, Wednesday, Otsuka Holdings, Thomson Locations: White Oak , Maryland, U.S, Japan, Europe, Bengaluru
0 next >>
Total: 2